EDGAR Filing Documents for 0001047469-08-009124

Form 10-Q - Quarterly report [Sections 13 or 15(d)]:

SEC Accession No. 0001047469-08-009124

Filing Date

2008-08-11

Accepted

2008-08-11 14:22:13

Documents

Period of Report

2008-06-30

Document Format Files

Seq	Description	Document	Type	Size
1	10-Q	a2186465z10-q.htm	10-Q	512336
2	EXHIBIT 3.1	a2186465zex-3_1.htm	EX-3.1	136906
3	EXHIBIT 10.1	a2186465zex-10_1.htm	EX-10.1	218177
4	EXHIBIT 10.2	a2186465zex-10_2.htm	EX-10.2	221398
5	EXHIBIT 10.3	a2186465zex-10_3.htm	EX-10.3	45339
6	EXHIBIT 10.4	a2186465zex-10_4.htm	EX-10.4	24261
7	EXHIBIT 10.5	a2186465zex-10_5.htm	EX-10.5	41951
8	EXHIBIT 10.6	a2186465zex-10_6.htm	EX-10.6	41839
9	EXHIBIT 10.7	a2186465zex-10_7.htm	EX-10.7	57800
10	EXHIBIT 10.8	a2186465zex-10_8.htm	EX-10.8	35977
11	EXHIBIT 31.1	a2186465zex-31_1.htm	EX-31.1	7551
12	EXHIBIT 31.2	a2186465zex-31_2.htm	EX-31.2	7558
13	EXHIBIT 32.1	a2186465zex-32_1.htm	EX-32.1	4238
14	G713773.JPG	g713773.jpg	GRAPHIC	2746
	Complete submission text file	0001047469-08-009124.txt		1360560

Mailing Address

Business Address 130 WAVERLY STREET CAMBRIDGE MA 02139-4242 6165776000

VERTEX PHARMACEUTICALS INC / MA (Filer) CIK: 0000875320 (see all company filings)